Does OLAPARIB Cause Thrombosis? 156 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Thrombosis have been filed in association with OLAPARIB (Lynparza). This represents 0.9% of all adverse event reports for OLAPARIB.
156
Reports of Thrombosis with OLAPARIB
0.9%
of all OLAPARIB reports
6
Deaths
48
Hospitalizations
How Dangerous Is Thrombosis From OLAPARIB?
Of the 156 reports, 6 (3.8%) resulted in death, 48 (30.8%) required hospitalization, and 2 (1.3%) were considered life-threatening.
Is Thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Thrombosis?
LENALIDOMIDE (6,433)
APIXABAN (5,298)
RIVAROXABAN (3,220)
ADALIMUMAB (2,334)
POMALIDOMIDE (1,158)
TOFACITINIB (1,143)
RITUXIMAB (1,083)
ETANERCEPT (1,051)
METHOTREXATE (981)
PREDNISONE (963)
Which OLAPARIB Alternatives Have Lower Thrombosis Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL